Search

everythinglearnresearchcommunity

for

Search:↓

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Minoxidil can cause a skin reaction called ALEP.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

308 excimer phototherapy is a safe and effective way to treat hair loss from Alopecia Areata.

Visible light can damage skin and most sunscreens don't block it well; more research is needed on its effects and protection methods.

Innate lymphoid cells help us understand and manage allergic diseases better.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

A stable sheep ovarian cell line was created for studying reproduction and hormones.

Skin stem cells were turned into heart cells using a chemical, suggesting a new way to treat heart attacks.

Certain drugs can cause skin lupus, but stopping the drug usually helps. Vaccines work against smallpox, genital herpes, and a type of human papillomavirus. More frequent light therapy clears psoriasis faster. Certain treatments work for psoriasis and dermatitis. A specific cream effectively treats a type of skin cancer. Low iron levels aren't directly linked to chronic hair loss.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

t-Flavanone helps improve male pattern hair loss by making hair roots stronger.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Male hormones can decrease the ability of immune cells to fight bacteria.

Current alopecia treatments manage symptoms but don't cure, and better treatments are needed.

Intermittent compression therapy is safe and doesn't harm tissue.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Single-cell encapsulation shows promise for medical use but faces production challenges.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

iPSC lines from different tissues share a common miRNA profile, supporting their pluripotent nature.

miR-21 helps improve ovarian function recovery in treated mice.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

Psoriasis patients have immune cells that respond more strongly to signals and stimuli due to an intrinsic cellular defect.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Ovol2 is crucial for hair growth and skin healing by controlling cell movement and growth.

Ethosomes are a promising way to deliver drugs through the skin.